Literature DB >> 11959802

The involvement of smooth muscle P2X receptors in the prolonged vasorelaxation response to purine nucleotides in the rat mesenteric arterial bed.

V Ralevic1.   

Abstract

1. ATP and adenine dinucleotides can elicit three different types of vasomotor response in the rat mesenteric arterial bed; vasocontraction, rapid relaxation (which may be masked by contraction) and slow and prolonged vasorelaxation. Contraction is mediated by smooth muscle P2X receptors and rapid relaxation by endothelial P2Y receptors. The mechanism of prolonged relaxation is, however, controversial. 2. In the present study, bolus injection of doses of alpha,beta-methylene ATP (alpha,beta-meATP; 5 pmol - 0.5 micromol; P2X receptor agonist) in methoxamine-preconstricted rat isolated mesenteric arterial beds, mimicked the action of ATP, causing contraction (R(max) 76+/-9 mmHg) followed by prolonged relaxation (78+/-11%; t(1/2) 14.6+/-1.5 min). KCl also elicited a biphasic response (R(max) contraction 73+/-8 mmHg; R(max) prolonged relaxation 70+/-6%; t(1/2) 7.7+/-1.9 min). 3. P2X receptor desensitization caused by perfusion with alpha,beta-meATP (10 microM) abolished contraction and prolonged relaxation to doses of alpha,beta-meATP (50 nmol). Rapid relaxation (32+/-7%; t(1/2) 32+/-2 s) was revealed, which was abolished by removal of the endothelium using distilled water. 4. Sodium deoxycholate treatment blocked contractile and prolonged relaxation responses to alpha,beta-meATP, ATP and KCl, whilst distilled water treatment had no significant effect on either phase of the biphasic responses. 5. These data indicate that smooth muscle P2X receptors are involved in both phases of the biphasic response (contraction followed by prolonged relaxation) to purine nucleotides in the rat isolated mesenteric arterial bed. Caution should be applied when using sodium deoxycholate to remove the endothelium because of possible damage caused by the detergent to receptors and/or the vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959802      PMCID: PMC1573326          DOI: 10.1038/sj.bjp.0704663

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Sp1-mediated downregulation of P2X4 receptor gene transcription in endothelial cells exposed to shear stress.

Authors:  R Korenaga; K Yamamoto; N Ohura; T Sokabe; A Kamiya; J Ando
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

3.  Ultrastructural localisation of ATP-gated P2X2 receptor immunoreactivity in vascular endothelial cells in rat brain.

Authors:  A Loesch; G Burnstock
Journal:  Endothelium       Date:  2000

4.  P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells.

Authors:  K Yamamoto; R Korenaga; A Kamiya; Z Qi; M Sokabe; J Ando
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

5.  Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid.

Authors:  R Glass; G Burnstock
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

6.  Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed.

Authors:  V Ralevic
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

7.  Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed.

Authors:  V Ralevic; J Jankowski; H Schlüter
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

8.  Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat.

Authors:  S J Stanford; J M Gitlin; J A Mitchell
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

9.  Fluid shear stress activates Ca(2+) influx into human endothelial cells via P2X4 purinoceptors.

Authors:  K Yamamoto; R Korenaga; A Kamiya; J Ando
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

10.  Vasoconstrictor responses induced by alpha-adrenoreceptor agonists before and after removal of the endothelial cells of dog mesenteric arteries.

Authors:  S Chiba; M Tsukada
Journal:  J Auton Pharmacol       Date:  1984-12
View more
  6 in total

1.  Novel role for P2X receptor activation in endothelium-dependent vasodilation.

Authors:  Louise S Harrington; Jane A Mitchell
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

2.  A delayed ATP-elicited K+ current in freshly isolated smooth muscle cells from mouse aorta.

Authors:  Karima Serir; Sebastien Hayoz; Mohammed Fanchaouy; Jean-Louis Bény; Rostislav Bychkov
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.

Authors:  M Alsaqati; S L F Chan; V Ralevic
Journal:  Purinergic Signal       Date:  2013-12-06       Impact factor: 3.765

Review 4.  Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.

Authors:  Erika B Westcott; Steven S Segal
Journal:  Microcirculation       Date:  2013-04       Impact factor: 2.628

5.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

6.  Purines and pyrimidines are not involved in NANC relaxant responses in the rabbit vaginal wall.

Authors:  Tom Ziessen; Selim Cellek
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.